Colon cancers with microsatellite instability are usually p53-normal and have a defective CHFR mitotic checkpoint, and are therefore an interesting target for AK301 (and similarly acting agents), particularly if they also have an APC mutation. This evidence concerns the gene TP53 and malignant colon neoplasm.